132 related articles for article (PubMed ID: 29520401)
21. From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents.
Lam NYS; Truong D; Burmeister H; Babak MV; Holtkamp HU; Movassaghi S; Ayine-Tora DM; Zafar A; Kubanik M; Oehninger L; Söhnel T; Reynisson J; Jamieson SMF; Gaiddon C; Ott I; Hartinger CG
Inorg Chem; 2018 Nov; 57(22):14427-14434. PubMed ID: 30406647
[TBL] [Abstract][Full Text] [Related]
22. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
23. Ru(ii)-(PTA) and -mPTA complexes with N
Wołoszyn A; Pettinari C; Pettinari R; Badillo Patzmay GV; Kwiecień A; Lupidi G; Nabissi M; Santoni G; Smoleński P
Dalton Trans; 2017 Aug; 46(30):10073-10081. PubMed ID: 28731114
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
26. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
27. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
28. Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group.
Mokesch S; Schwarz D; Hejl M; Klose MHM; Roller A; Jakupec MA; Kandioller W; Keppler BK
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252521
[TBL] [Abstract][Full Text] [Related]
29. Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.
Biersack B
Mini Rev Med Chem; 2016; 16(10):804-14. PubMed ID: 27161009
[TBL] [Abstract][Full Text] [Related]
30. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
31. Anticancer Ru(η
Arshad J; Hanif M; Movassaghi S; Kubanik M; Waseem A; Söhnel T; Jamieson SMF; Hartinger CG
J Inorg Biochem; 2017 Dec; 177():395-401. PubMed ID: 28916262
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the antiproliferative activity of [RuCp(PPh
Mendoza Z; Lorenzo-Luis P; Scalambra F; Padrón JM; Romerosa A
Dalton Trans; 2017 Jun; 46(25):8009-8012. PubMed ID: 28617514
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, DNA Cleavage Activity, Cytotoxicity, Acetylcholinesterase Inhibition, and Acute Murine Toxicity of Redox-Active Ruthenium(II) Polypyridyl Complexes.
Alatrash N; Narh ES; Yadav A; Kim MJ; Janaratne T; Gabriel J; MacDonnell FM
ChemMedChem; 2017 Jul; 12(13):1055-1069. PubMed ID: 28605571
[TBL] [Abstract][Full Text] [Related]
34. Triazole-based, optically-pure metallosupramolecules; highly potent and selective anticancer compounds.
Song H; Rogers NJ; Brabec V; Clarkson GJ; Coverdale JPC; Kostrhunova H; Phillips RM; Postings M; Shepherd SL; Scott P
Chem Commun (Camb); 2020 Jun; 56(47):6392-6395. PubMed ID: 32390012
[TBL] [Abstract][Full Text] [Related]
35. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
36. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
37. Half-sandwich RuCl2(η(6)-p-cymene) core complexes containing sulfur donor aroylthiourea ligands: DNA and protein binding, DNA cleavage and cytotoxic studies.
Jeyalakshmi K; Haribabu J; Bhuvanesh NS; Karvembu R
Dalton Trans; 2016 Aug; 45(31):12518-31. PubMed ID: 27435011
[TBL] [Abstract][Full Text] [Related]
38. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
[TBL] [Abstract][Full Text] [Related]
39. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
